Renal Department, Salford Royal NHS Trust, Salford, United Kingdom.
University of Manchester, Oxford Road, Manchester, United Kingdom.
PLoS One. 2019 May 7;14(5):e0216412. doi: 10.1371/journal.pone.0216412. eCollection 2019.
Most sepsis and acute kidney injury (AKI) cases are community acquired (CA). The aim of this study was to evaluate the characteristics of suspected community acquired infection (sCA-I) and CA-AKI and their impact upon patient outcomes.
All adult creatinine blood tests from non-elective, non-dialysis attendances to a single centre over a 29-month period were analysed retrospectively. We defined sCA-I and CA-AKI cases as antibiotic prescription and AKI alert within 48 hours of attendance respectively. Binary logistic regression models were created to determine associations with 30-day mortality, intensive care unit (ICU) admission and length of stay (LOS) dichotomised at median.
Of 61,471 attendances 28.1% and 5.7% suffered sCA-I or CA-AKI in isolation respectively, 3.4% suffered both. sCA-I was present in 58.8% of CA-AKI cases and CA-AKI was present in 11.9% of CA-I cases. The combination of sCA-I and CA-AKI was associated with a higher risk for all outcomes compared to sCA-I or CA-AKI in isolation. The 30-day mortality was 8.1%, 11.8% and 26.2% in patients with sCA-I, CA-AKI and when sCA-I and CA-AKI occurred in combination respectively. The adjusted odds ratios (OR) and 95% confidence intervals (CI) for 30-day mortality, ICU admission and LOS for sCA-I combined with CA-AKI stage 1 were OR 6.09:CI: 5.21-7.12, OR 12.52 CI: 10.54-14.88 and OR 8.97 CI: 7.62-10.56, respectively, and for combined sCA-I and CA-AKI stage 3 were OR 9.23 CI: 6.91-12.33, OR 29.26 CI: 22.46-38.18 and OR 9.48 CI: 6.82-13.18 respectively.
The combination of sCA-I and CA-AKI is associated with worse outcomes.
大多数脓毒症和急性肾损伤(AKI)病例为社区获得性(CA)。本研究旨在评估疑似社区获得性感染(sCA-I)和 CA-AKI 的特征及其对患者预后的影响。
对单中心 29 个月内所有非择期、非透析成人肌酐血检进行回顾性分析。我们将抗生素处方和就诊后 48 小时内 AKI 警报分别定义为 sCA-I 和 CA-AKI 病例。采用二元逻辑回归模型确定与 30 天死亡率、重症监护病房(ICU)入住和住院时间(LOS)相关的因素,两者均以中位数进行二分类。
在 61471 次就诊中,分别有 28.1%和 5.7%的患者孤立性出现 sCA-I 或 CA-AKI,3.4%的患者同时出现两种情况。sCA-I 出现在 58.8%的 CA-AKI 病例中,CA-AKI 出现在 11.9%的 CA-I 病例中。与 sCA-I 或 CA-AKI 单独发生相比,sCA-I 和 CA-AKI 同时发生与所有结局的风险增加相关。sCA-I、CA-AKI 和 sCA-I 合并 CA-AKI 患者的 30 天死亡率分别为 8.1%、11.8%和 26.2%。sCA-I 合并 CA-AKI 1 期患者 30 天死亡率、ICU 入住率和 LOS 的调整比值比(OR)和 95%置信区间(CI)分别为 6.09:CI:5.21-7.12、12.52 CI:10.54-14.88 和 8.97 CI:7.62-10.56,sCA-I 合并 CA-AKI 3 期患者分别为 9.23 CI:6.91-12.33、29.26 CI:22.46-38.18 和 9.48 CI:6.82-13.18。
sCA-I 合并 CA-AKI 与不良结局相关。